Solidea in the Top 20 in LiveSTRONG’s The Big C Competition
One of our newest brands of compression garments – Solidea – has been named as a Semi-Finalist in The Big C Competition. In its inaugural year, the Big C Competition hopes to drive and support innovations that improve the quality of life for cancer patients and their families. Solidea was one of 750 companies that entered this year’s competition.
The Top 20 companies represent projects from six countries on four continents and 10 states within the U.S. When LiveSTRONG announced the competition, it said it was “open to entrepreneurs, trailblazers, technology whizzes, fashionistas, medical geeks, game changers and anyone with an audacious product, service or innovation that helps those facing cancer today.” The range of companies and products in the final 20 is truly impressive. It includes, a smart pill bottle to improve medication adherence, wireless orthopedic bras, and a web platform that helps make relocating for medical treatment less daunting, among other companies and products. The finalists are all remarkable, and we’re so excited that Solidea was included in this group. Learn more about the Top 20 and the Big C Competition here.
BrightLife Direct began carrying Solidea products one year ago and the response has been great! Over the past year, some of the best selling Solidea products have been the Ankle Socks, the Advanced MicroMassage Capris, and the Wonder Model Pantyhose. What we’d really love to highlight is the compression armsleeves which have been real game-changers for many of our lymphedema patients:
Unilateral Compression Armsleeve – For anyone who has edema in just one arm, this is a great option. Customers love the effective massaging fabric, but also that there is no need for a silicone top band. Many armsleeve wearers have adverse reactions to a silicone band pinching into their skin or causing rashes. This sleeve comes up and over the shoulder in a truly innovative design.
Check out their sizable collection of compression products here.